Specialty Pharma Journal Specialty, Precision & Technology
MANHATTAN BEACH, Calif., Jan. 4, 2018 /PRNewswire-USNewswire/ — Pancreatic cancer remains the deadliest major cancer with a five-year survival of just 9 percent*, according to the Cancer Facts & Figures report released today by the American Cancer Society. “More than 55,000 Americans – mothers, daughters, fathers, sons, colleagues and friends …
Tag Archives: Pancreatic Cancer Action Network
January, 2018
April, 2017
-
12 April
Pancreatic Cancer Pathway Identified; Discovery May Broach New Era of Effective Immunotherapies for the Deadliest Major Cancer
MANHATTAN BEACH, Calif.–(BUSINESS WIRE)–Pancreatic Cancer Action Network (PanCAN) grantee George Miller, MD, and his research team at NYU Langone Medical Center, discovered a novel and potentially targetable way that pancreatic cancer cells hide themselves from the immune system. The findings, published today in the journal Nature Medicine, have the potential …
October, 2015
-
22 October
Merrimack Pharmaceuticals’ Pancreatic Cancer Drug Wins Expedited FDA Approval
MANHATTAN BEACH, Calif., Oct. 22, 2015 /PRNewswire-USNewswire/ — Today, The U.S. Food and Drug Administration (FDA) approved a novel therapy for patients with metastatic pancreatic adenocarcinoma – the most common form of pancreatic cancer – whose disease has progressed following gemcitabine-based therapy, offering new hope against a disease that will claim …